Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Hematology
•
Autoinflammatory disorders
•
VEXAS
Which other agent would you consider for a patient with VEXAS who has failed methotrexate, multiple TNF inhibitors, Tocilizumab and Ruxolitinib?
Related Questions
What is your approach to the diagnosis of LGL leukemia or Felty's Syndrome in a patient with rheumatoid arthritis?
What is your approach to DVT prophylaxis in patients who require IVIG but are at increased risk for thrombotic events?
How would you manage a case of subcutaneous panniculitis-like T cell lymphoma (A/B) who is already on steroids and methotrexate for autoimmune disease?
What is your approach to RSV vaccination in immunocompromised patients?
When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
How would you manage warfarin in a patient with APLS and alcoholic cirrhosis?
Would you start anticoagulation in a patient with provoked blood clot in the past now with labs done for rheumatological reasons showing triple positive APLA?
How do you decide when to obtain genetic testing for suspected autoinflammatory conditions in adults?
How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
